Ribbon Biolabs
David A. Maier serves as CFO and Geschäftsführer at Ribbon Biolabs since May 2022 and holds the same position at Themis Bioscience GmbH since August 2015, where responsibilities include overseeing financial operations. As an Expert Witness for Forecasting and Valuation since September 2015, David A. Maier provides expert opinions for small- and medium-sized companies in legal matters and advisory roles. In addition, David A. Maier founded INTERES in October 2014, emphasizing a results-oriented consulting approach. Previous experience includes positions on the supervisory board and as interim CFO for various companies, as well as senior roles in investment banking and private equity. David A. Maier holds a degree from WU (Vienna University of Economics and Business) and has an educational background in chemical engineering from HTL Chemie Wien XVII.
This person is not in any teams
This person is not in any offices
Ribbon Biolabs
Let’s write the future of DNA. Ribbon Biolabs is a biotech start-up working on developing the next technological wave of error-proof DNA synthesis. With its approach, company is developing a cost-efficient platform to produce long and complex DNA molecules, thereby enabling a new generation of biopharmaceutical processes and other synthetic biology products. Our international and highly motivated team located in Vienna is constantly looking for new talents who can join this exciting ride and take Ribbon Biolabs to the next level.